Compare SPOK & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPOK | PMI |
|---|---|---|
| Founded | 2004 | 1981 |
| Country | United States | United States |
| Employees | 415 | 75 |
| Industry | Telecommunications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.6M | 14.1M |
| IPO Year | 2004 | N/A |
| Metric | SPOK | PMI |
|---|---|---|
| Price | $10.63 | $0.15 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 171.3K | ★ 13.2M |
| Earning Date | 04-29-2026 | 06-18-2026 |
| Dividend Yield | ★ 11.31% | N/A |
| EPS Growth | ★ 2.74 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $139,708,000.00 | N/A |
| Revenue This Year | $1.70 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $117.00 | ★ N/A |
| Revenue Growth | ★ 1.49 | N/A |
| 52 Week Low | $9.95 | $0.11 |
| 52 Week High | $19.31 | $13.68 |
| Indicator | SPOK | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 40.16 | 20.71 |
| Support Level | $9.95 | N/A |
| Resistance Level | $11.55 | $0.27 |
| Average True Range (ATR) | 0.22 | 0.03 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 29.86 | 24.65 |
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.